Blue Biofuels (BIOF) Common Equity (2012 - 2026)

Blue Biofuels (BIOF) has reported Common Equity for 15 consecutive years, with -$4.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Common Equity fell 27.95% year-over-year to -$4.1 million in Q2 2026; TTM through Jun 2026 was -$4.1 million, a 27.95% decrease from a year earlier, with the FY2025 full-year figure at $1.0 billion, up 35238.23% from the prior year.
• Common Equity was -$4.1 million for Q2 2026 at Blue Biofuels, down from -$3.7 million in the prior quarter.
• Over five years, Common Equity peaked at -$2.0 million in Q2 2022 and troughed at -$4.8 million in Q2 2024.
• A 5-year average of -$3.0 million and a median of -$3.1 million in 2025 frame the typical range for Common Equity.
• Across the five-year window, Common Equity sank 581.45% in 2022 and soared 33.26% in 2025, its largest moves.
• Over 5 years, Common Equity stood at -$2.4 million in 2022, then sank by 51.09% to -$3.6 million in 2023, then advanced by 20.08% to -$2.8 million in 2024, then sank by 30.23% to -$3.7 million in 2025, then fell by 9.51% to -$4.1 million in 2026.
• The last three Common Equity figures came in at -$4.1 million (Q2 2026), -$3.7 million (Q4 2025), and -$3.1 million (Q3 2025), per Business Quant data.